Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

Slides:

Advertisements

Similar presentations

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles Ryan G. Steward,

Advertisements

In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option? Marine Quinquin,

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation? Micah.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Is the effect of premature elevated progesterone augmented by human chorionic gonadotropin versus gonadotropin-releasing hormone agonist trigger? Matthew.

Report of results obtained in 2,934 women using donor sperm: donor insemination versus in vitro fertilization according to indication Thamara Viloria,

Effect of chronic hypertension on assisted pregnancy outcomes: a population-based study in Ontario, Canada Natalie Dayan, M.D., Andrea Lanes, M.Sc.,

Ovarian reserve and subsequent assisted reproduction outcomes after methotrexate therapy for ectopic pregnancy or pregnancy of unknown location Micah.

Patient and cycle characteristics predicting high pregnancy rates with single-embryo transfer: an analysis of the Society for Assisted Reproductive Technology.

Taylor P. Kohn, M. Phil. , Jaden R. Kohn, B. S. , Alexander W

No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women.

Michael M. Alper, M.D. Fertility and Sterility

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Karen Purcell, M. D. , Ph. D. , Michael Schembri, M. S. , Linda M

What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis.

Trophectoderm grade predicts outcomes of single-blastocyst transfers

Isiah D. Harris, M. D. , Johanne Python, M. D. , Lauren Roth, M. D

Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective randomized study Leonidas Mamas, M.D., Ph.D.

Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after.

Examining the temperature of embryo culture in in vitro fertilization: a randomized controlled trial comparing traditional core temperature (37°C) to.

Live birth of twins derived from zona-free oocytes

Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D.

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient.

Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes Jin-Ho Lim, M.D., Seong-Ho Yang,

In vitro fertilization versus conversion to intrauterine insemination in Bologna-criteria poor responders: how to decide which option? Marine Quinquin,

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Intracytoplasmic sperm injection in partial globozoospermia

Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis Micah J. Hill, D.O., Brian.

Influences on endometrial development during intrauterine insemination: clinical experience of 2,929 patients with unexplained infertility Erin Foran.

Marcus W. Jurema, M. D. , Andrea D. Vieira, M. D

Mieke Carine Wim Eeckhaut, Ph.D. Fertility and Sterility

Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: a new approach to.

Success of intrauterine insemination in women aged 40–42 years

Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates Amy.

A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization Laura Detti, M.D., Daniel B. Williams, M.D., Jared.

Dmitry M. Kissin, M. D. , M. P. H. , Jennifer F. Kawwass, M. D

Revisiting the progesterone to oocyte ratio

Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive.

Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles Karin.

Cost-effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low.

Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer Shokichi Teramoto,

Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.

Birth outcomes after spontaneous or assisted conception among infertile Australian women aged 28 to 36 years: a prospective, population-based study Danielle.

Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: Results of 4,062 intrauterine insemination.

Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.

In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular.

One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above Sigal Klipstein, M.D., Meredith.

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.

Bruce S Shapiro, M. D. , Kevin S Richter, Ph. D. , Dee C Harris, M. T

Jcoe Glenn Proctor, B.S., William R. Boone, Ph.D.

Regulation of assisted reproductive technologies in the United States

Fertility and Sterility: an evaluation

Eric S. Surrey, M. D. , Debra A. Minjarez, M. D. , John M. Stevens, B

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

When is clomiphene or gonadotropin intrauterine insemination futile

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles

Use of recombinant human chorionic gonadotropin in ovulation induction

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing.

In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review.

Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:

The cumulative probability of liveborn multiples after in vitro fertilization: a cohort study of more than 10,000 women Beth A. Malizia, M.D., Laura.

Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles John L. Frattarelli,

Presentation transcript:

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens, M.D., Kevin S. Richter, Ph.D., Eric A. Widra, M.D., Michael J. Levy, M.D. Fertility and Sterility Volume 94, Issue 6, Pages 2073-2077 (November 2010) DOI: 10.1016/j.fertnstert.2009.12.056 Copyright © 2010 Terms and Conditions

Figure 1 Live birth rates in first IVF cycles that resulted in either an IVF-to–intrauterine insemination (IUI) conversion or oocyte retrieval with one, two, three, or four follicles ≥14 mm on the day of hCG trigger. Values shown: number of patients; mean patient age, peak E2 level, and live birth rate. Fertility and Sterility 2010 94, 2073-2077DOI: (10.1016/j.fertnstert.2009.12.056) Copyright © 2010 Terms and Conditions